Inbiomotion receives funding through the EU's Horizon 2020 programme


In the final round of selection, the European Union's  Horizon 2020 programme has chosen two Catalan start-ups from the health sector: Inbiomotion and Peptomyc, which will receive €50,000 to fund their innovative projects and carry out feasibility studies on new ideas and products.

Inbiomotion, founded by Dr. Roger Gomis (ICREA research professor), is a spin-off of the IRB Barcelona and ICREA that was launched in late 2010 to develop biomarkers to predict bone metastasis in cancer patients from biopsies of primary tumors.

Read more here:
(English) http://www.biocat.cat/en/news/inbiomotion-and-peptomyc-receive-funding-through-european-horizon-2020-program

(Spanish) http://www.interempresas.net/Farmacia/Articulos/152129-Inbiomotion-y-Peptomyc-reciben-financiacion-del-programa-europeo-Horizon-2020.html